Daunomycin-induced cardiotoxicity in children and adults

作者: Daniel D. Von Hoff , Marcel Rozencweig , Maxwell Layard , Milan Slavik , Franco M. Muggia

DOI: 10.1016/0002-9343(77)90315-1

关键词: DaunorubicinHeart failureMedicineCardiologyCardiomyopathyElectrocardiographyCardiotoxicityRetrospective cohort studyInternal medicineAnthracyclineSurgeryRelative risk

摘要: Daunomycin, like its anthracycline analog adriamycin, is a cardiotoxic antitumor antibiotic. Reports on 5,613 patients receiving daunomycin were reviewed for cardiotoxicity. Two distinct patterns of cardiotoxicity defined, congestive heart failure (cardiomyopathy) and electrocardiographic changes. Dose-response curves constructed using the percent incidence cardiomyopathy versus total dose in mg/m2. There was dose-response relationship between development cardiomyopathy, both children adults. The seem more susceptible to drug-induced cardiomyopathy. changes adults did not show dose-dependent relationship, present consistently even at lowest dosage levels, predict subsequent enable clinician judge relative risk developing given level allows comparison human experience with experimental animal model data.

参考文章(16)
G. Mathé, M. Hayat, L. Schwarzenberg, J.L. Amiel, M. Schneider, A. Cattan, J.R. Schlumberger, C. Jasmin, ACUTE LYMPHOBLASTIC LEUKÆMIA TREATED WITH A COMBINATION OF PREDNISONE, VINCRISTINE, AND RUBIDOMYCIN: Value of Pathogen-free Rooms The Lancet. ,vol. 290, pp. 380- 383 ,(1967) , 10.1016/S0140-6736(67)92004-1
Farid I. Haurani, Oliver Glidewell, Janet Cuttner, Geoffrey Falkson, Lucius F. Sinks, E. Omer Burgert, Johannes Blom, Barbara Jones, R. Jackson Forcier, John H. Moon, Louise Chevalier, Faith Kung, Arthur Sawitsky, Stanley L. Lee, James F. Holland, Alan R. Morrison, Aaron Rausen, Hans J. Pluss, Maurice M. Albala, Richard B. Patterson, Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia. Cancer Research. ,vol. 31, pp. 84- 90 ,(1971)
Farid Haurani, Oliver J. Glidewell, Janet Cuttner, Salman Gailani, Johannes Blom, Jean Bernard, Robert Levy, M. Robert Cooper, Vishram B. Rege, Marise Weil, Rose Ruth Ellison, Nis I. Nissen, Claude Jacquillat, Richard T. Silver, James F. Holland, Louis Lowenstein, Arthur A. Serpick, Kurt Brunner, Barth Hoogstraten, Michel Boiron, Peter H. Wiernik, Louis Wasserman, Daunorubicin in the Therapy of Acute Granulocytic Leukemia Cancer Research. ,vol. 33, pp. 921- 928 ,(1973)
Angela C. Gilladoga, Corazon Manuel, Charlotte T. C. Tan, Norma Wollner, Stephen S. Sternberg, M. Lois Murphy, The cardiotoxicity of adriamycin and daunomycin in children. Cancer. ,vol. 37, pp. 1070- 1078 ,(1976) , 10.1002/1097-0142(197602)37:2+<1070::AID-CNCR2820370814>3.0.CO;2-6
G Bonadonna, S Monfardini, AlbertoM Marmont, E Damasio, F Rossi, Cardiac toxicity of daunorubicin. The Lancet. ,vol. 1, pp. 837- 838 ,(1969) , 10.1016/S0140-6736(69)92093-5
Jarir F. Halazun, Henry R. Wagner, John F. Gaeta, Lucius F. Sinks, Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia Cancer. ,vol. 33, pp. 545- 554 ,(1974) , 10.1002/1097-0142(197402)33:2<545::AID-CNCR2820330233>3.0.CO;2-M
J MALPAS, DAUNORUBICIN IN ACUTE MYELOCYTIC LEUKÆMIA The Lancet. ,vol. 293, pp. 469- 470 ,(1969) , 10.1016/S0140-6736(69)91516-5
Charlene P. Holton, Chairman Derrick Lonsdale, Audrey H. Nora, William G. Thurman, Teresa J. Vietti, Clinical study of daunomycin (NSC-82151) in children with acute leukemia Cancer. ,vol. 22, pp. 1014- 1017 ,(1968) , 10.1002/1097-0142(196811)22:5<1014::AID-CNCR2820220517>3.0.CO;2-F